The performance of innovative research on Alzheimer and dementia and non-AD dementias in the context of brain aging increasinglyrequires synergisticinteractionsbetweenclinical branches of agiven study, pathologicalinformationand modern and sophisticatedgenetic analyses. Furthermore,a critical step in progress towards understandingthe pathophysiology (and thus ultimately treatment) of different forms of dementia is assessing how different genotypes contribute to variability in disease phenotype. This type of correlation is a preamble to the equally importantgoal of understandinggene-environment interactions. The UCLA Core for The Genetic Analysis of FTLD is an integrated, state-of-the art laboratory that studies the Genetics and Molecular Biology of Frontotemporal Dementia and related dementias. The Core leverages the clinical strengths of the UCSF Center for Memory and Aging and Alzheimer's Disease Research Center (ADRC), as well as the UCSF investigators' longitudinal studies of dementia that provides clinical material for research projects. To further understand FTLD genetics and establish more specific genetic markers of the disease the work of the core sets several Specific Aims which include: 1) collection and banking of DMA on subjects with FTLD, AD and control subjects; 2) genotyping for known genetic risk factors (e.g. ApoE, Tau, Prion protein and PS-1); 3) exploratory investigation of RNA expression profiles for biomarker discovery and patient classification using microarray technology, and 4) development of interdisciplinary collaborations and research training. The fundamental purpose of this core is service, and the data obtained will be highly supportive and useful for other ongoing hypothesis driven projects in the PPG. The Genetic Core will also provide genetic screening and will perform genotyping studies of familial FTLD and AD. These core services build upon the laboratory's expertise derived from previous and ongoing, synergistic, genetic projects involving assessment of genetic risk factors and neurobehavioral phenotypes in FTLD, sequencing of genes related to tau to identify novel genetic risk factors for FTLD and AD, functional genomic based biomarker discovery and microarray based profiling of individuals for peripheral biomarkers using peripheral tissues and established cell lines. In this way, the core provides the necessary genetic foundation for the PPG by leveraging existing expertise and resources, thus delivering its services in the most efficient manner.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG019724-07
Application #
7676832
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2008-09-01
Budget End
2009-08-31
Support Year
7
Fiscal Year
2008
Total Cost
$144,030
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Karch, Celeste M; Wen, Natalie; Fan, Chun C et al. (2018) Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum. JAMA Neurol 75:860-875
Staffaroni, Adam M; Brown, Jesse A; Casaletto, Kaitlin B et al. (2018) The Longitudinal Trajectory of Default Mode Network Connectivity in Healthy Older Adults Varies As a Function of Age and Is Associated with Changes in Episodic Memory and Processing Speed. J Neurosci 38:2809-2817
Seo, Sang Won; Thibodeau, Marie-Pierre; Perry, David C et al. (2018) Early vs late age at onset frontotemporal dementia and frontotemporal lobar degeneration. Neurology 90:e1047-e1056
Santos-Santos, Miguel A; Rabinovici, Gil D; Iaccarino, Leonardo et al. (2018) Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia. JAMA Neurol 75:342-352
Bergeron, David; Gorno-Tempini, Maria L; Rabinovici, Gil D et al. (2018) Prevalence of amyloid-? pathology in distinct variants of primary progressive aphasia. Ann Neurol 84:729-740
Björkhem, Ingemar; Patra, Kalicharan; Boxer, Adam L et al. (2018) 24S-Hydroxycholesterol Correlates With Tau and Is Increased in Cerebrospinal Fluid in Parkinson's Disease and Corticobasal Syndrome. Front Neurol 9:756
Pottier, Cyril; Zhou, Xiaolai; Perkerson 3rd, Ralph B et al. (2018) Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study. Lancet Neurol 17:548-558
Theofilas, Panos; Ehrenberg, Alexander J; Nguy, Austin et al. (2018) Probing the correlation of neuronal loss, neurofibrillary tangles, and cell death markers across the Alzheimer's disease Braak stages: a quantitative study in humans. Neurobiol Aging 61:1-12
Eser, Rana A; Ehrenberg, Alexander J; Petersen, Cathrine et al. (2018) Selective Vulnerability of Brainstem Nuclei in Distinct Tauopathies: A Postmortem Study. J Neuropathol Exp Neurol 77:149-161
Deleon, Jessica; Miller, Bruce L (2018) Frontotemporal dementia. Handb Clin Neurol 148:409-430

Showing the most recent 10 out of 607 publications